{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreicudon2h6is6hsurmgmvqb4chs3sqcqulniyvquuzamwtbha7qdkq",
    "uri": "at://did:plc:xc32dedgv3ceunwz2nrseso4/app.bsky.feed.post/3mjxiujp4hdz2"
  },
  "path": "/x/837e99e4de0ca6d3?ref=rss",
  "publishedAt": "2026-04-20T22:06:31.000Z",
  "site": "https://upstract.com",
  "textContent": "Eli Lilly is spending $3.25 billion to acquire Kelonia Therapeutics, a small biotech company developing cell therapies for cancer and autoimmune diseases, the companies announced Monday. Lilly could pay more if Kelonia achieves specified clinical, regulatory, and commercial milestones. The…",
  "title": "Eli Lilly’s $3.25 billion acquisition of Kelonia Therapeutics caps startup’s tortuous ride"
}